Biohaven eyes mid-2021 for migraine prevention drug launch
-
Den her vil sikkert interessere Teva-aktionaerer paa forum:
Biohaven eyes mid-2021 for migraine prevention drug launch
https://www.cnbc.com/2020/11/18/biohaven-eyes-mid-2021-for-migraine-prevention-drug-launch-.html
"I hope that in six months or so from now that we will be the first oral CGRP with the indication for the prevention of migraine," Biohaven Pharmaceutical CEO Vlad Coric told CNBC.Er der nogen, der ved, hvor/om man kan se, hvilke aktier, der er de mest populaere paa Nordnet ift markedsvaerdi, antal aktionaerer, flest nye aktionaerer i forrige uge, etc. i stil med robintrack.net? Jeg spoerger, fordi jeg spekulerer, hvor mange, der stadig har aktier i Teva. Jeg kan huske, at Per Hansen fra Nordnet sagde, at den var enormt populaer i 2017. Hvis jeg husker rigtigt, saa var den dengang nede at vende i kurs 11.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind